Mohammad Usman Shaikh
Overview
Explore the profile of Mohammad Usman Shaikh including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
68
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Shaikh M, Ahmed Z, Shaikh M, Adil S, Khurshid M, Moatter T, et al.
Asian Pac J Cancer Prev
. 2018 Jul;
19(7):1903-1906.
PMID: 30049204
Objectives: The heterogenous response to treatment in acute myeloid leukemia (AML) can be attributed largely to
the difference in cytogenetic features identified in between cases. Cytogenetic analysis in acute leukemia...
12.
Shaikh M, Shaikh M, Adil S, Khurshid M, Ahmed Z
J Ayub Med Coll Abbottabad
. 2017 Jul;
28(2):293-297.
PMID: 28718562
Background: The "Philadelphia Negative Classic Myeloproliferative Neoplasms" include polycythaemia vera (PV), essential thrombocythaemia (ET) and idiopathic myelofibrosis (IMF). These three disorders share several clinical and laboratory features including JAK2 V617F...
13.
Iqbal N, Usman Tariq M, Shaikh M, Majid H
BMJ Case Rep
. 2016 Aug;
2016.
PMID: 27520995
Multiple myeloma is a clonal B-cell malignancy, characterised by proliferation of plasma cells and secretion of paraproteins. These plasma cells accumulate predominantly in the bone marrow; rarely, they invade other...
14.
Hussain S, Shaikh M
Clin Ther
. 2015 Sep;
37(11):2449-57.
PMID: 26409289
Purpose: The purpose of this study was to determine the frequency of major cytogenetic response (MCyR) and adverse events with nilotinib in adults with imatinib-resistant Philadelphia chromosome-positive chronic myeloid leukemia...
15.
Ali N, Adil S, Shaikh M
Stem Cells Transl Med
. 2015 Jun;
4(8):873-7.
PMID: 26032748
Intensive chemotherapy followed by autologous stem cell transplantation is the treatment of choice for patients with hematological malignancies. The objective of the present study was to evaluate the outcomes of...
16.
Zahid M, Ali N, Shaikh M, Adil S
Int J Hematol Oncol Stem Cell Res
. 2015 Mar;
8(4):30-8.
PMID: 25774265
Introduction: Allogeneic hematopoietic stem cell transplantation is a potentially curative treatment modality for hematological malignancies. We evaluated the outcome of patients suffering from hematological malignancies, including acute leukemias, chronic myeloid...
17.
Shaikh M, Adil S, Shaikh M, Khurshid M
Asian Pac J Cancer Prev
. 2014 Nov;
15(21):9495-8.
PMID: 25422245
Background: The difference in prognosis of adult and childhood acute lymphoblastic leukemia (ALL) can be attributed largely to variation in cytogenetic abnormalities with age groups. Cytogenetic analysis in acute leukemia...
18.
Ali N, Adil S, Shaikh M, Masood N
ISRN Hematol
. 2013 Aug;
2013:232519.
PMID: 23936661
Objective. The objective of this study was to evaluate the frequency and outcome of graft versus host disease after stem cell transplantation for various haematological disorders in Pakistan. Materials and...
19.
Ali N, Adil S, Shaikh M, Masood N
Hematol Rep
. 2013 Jan;
4(4):e25.
PMID: 23355943
We report a case series of 12 patients with acute myeloid leukemia who underwent allogeneic stem cell transplant with a matched related donor. Male to female ratio was 1:1. The...
20.
Ali N, Adil S, Shaikh M, Moosajee M, Masood N
Exp Hematol Oncol
. 2012 Dec;
1(1):13.
PMID: 23210643
We present our initial experience of allogeneic stem cell transplant procedure performed between April 2004 and August 2011 for various haematological disorders. All patients with non-malignant and malignant haematological disorders...